Intriguingly, the over-expression of HO-1 has been also detected in lymphocytes and plasma from AD subjects, thus putting forth the hypothesis that HO-1 is a peripheral biomarker of AD (Calabrese et al., 2006; Di Domenico et al., 2012). This evidence concerns the gene HMOX1 and Alzheimer disease.